Work

Global Treatment Standard in Multiple Myeloma Remains Elusive: Updated Results from the INSIGHT MM Global, Prospective, Observational Study

Year: 2022

Type: article

Study design: Observational Study

Source: Blood

DOI: 10.1182/blood-2022-163074

Authors: Noemi Puig, Vania T.M. Hungria, Ajai Chari, Faith E. Davies, Gordon Cook, Roman Hájek, Kathryn E. Morgan, Jim Omel, Evangelos Terpos, Michael A. Thompson, Saad Usmani, Jorge Vela-Ojeda, Katja Weisel, Mira Armour, Kaili Ren, Dasha Cherepanov, Dawn Marie Stull, Jesus Berdeja

Institutions: Instituto de Investigación Biomédica de Salamanca, São Germano Oncologia, Icahn School of Medicine at Mount Sinai, NYU Langone Health, NYU Langone’s Laura and Isaac Perlmutter Cancer Center, Leeds Teaching Hospitals NHS Trust, University of Ostrava, University Hospital Ostrava, National and Kapodistrian University of Athens, Aurora Health Care, Tempus Labs (United States), Levine Cancer Institute, Mexican Social Security Institute, Centro Médico Nacional La Raza, University Medical Center Hamburg-Eppendorf, Tennessee Oncology

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4310106236

FWCI: 0.623

Cites:

Cited by: 4

Related to: 10